PHIO PHARMACEUTICALS CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.245 USD | +0.33% |
|
-15.78% | -23.32% |
Chart calendar Phio Pharmaceuticals Corp.
4ad6ffb0c199b6b77e278.VHNfnz7TSaF0knboshpPv6K0MoLni4Ip2ESBoUW24R4.bEssz1uCAPsG-hSEwmAWiu3lWuvW09daiirlkB_3pG0BCj2vSeMC1yfcTg~4ed7f5b5c3d5f4a65be5fe9e8b34c9a9
Upcoming events on Phio Pharmaceuticals Corp.
Past events on Phio Pharmaceuticals Corp.
| 2024-06-17 09:00 | Annual General Meeting |
| 2024-05-16 17:30 | Society for Investigative Dermatology Meeting - Abstract No: 283 |
| 2024-05-16 17:30 | Society for Investigative Dermatology Meeting - Abstract No: 576 |
| 2024-05-16 17:30 | Society for Investigative Dermatology Meeting - Abstract No: 575 |
| 2024-05-09 17:25 | Q1 2024 Earnings Release |
| 2024-05-08 12:00 | American Society of Gene & Cell Therapy Meeting - Abstract Number:774 |
| 2024-04-02 07:30 | Q4 2023 Earnings Release |
| 2024-03-22 13:00 | Immunotherapy of Cancer Conference |
| 2024-03-21 13:00 | Immunotherapy of Cancer Conference |
| 2024-03-21 13:00 | Immunotherapy of Cancer Conference - Poster No : P01.03 |
| 2023-11-09 16:30 | Q3 2023 Earnings Release |
| 2023-11-04 12:00 | Society for Immunotherapy of Cancer Meeting - Abstract Number : 474 |
| 2023-10-14 12:30 | AACR NCI EORTC International Conference - INTASYL™ self-delivering RNAi therapeutic targeting BRD4 e |
| 2023-10-14 12:30 | AACR NCI EORTC International Conference - INTASYL™ PH-894 self-delivering RNAi targeting BRD4 |
| 2023-09-11 07:00 | H.C. Wainwright Global Investment Conference |
| 2023-08-10 16:30 | Q2 2023 Earnings Release |
| 2023-07-20 09:00 | Annual General Meeting |
| 2023-05-17 15:00 | American Society of Gene & Cell Therapy Meeting - Abstract No: 544 |
| 2023-05-11 17:00 | Q1 2023 Earnings Release |
| 2023-04-18 13:30 | American Association for Cancer Research Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,02 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -8,99 -8,60 -4.5% | -8,79 -8,80 0.08% | -13,5 -14,4 6.17% | -11,5 -12,4 7.56% | -10,8 -12,0 9.8% | -9,60 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,91 -8,50 -4.8% | -8,79 -8,80 0.07% | -13,3 -14,2 6.43% | -11,5 -12,4 7.42% | -10,8 -12,0 9.78% | -9,60 |
|
Net income Million USD | Released Forecast Spread | -8,91 -8,50 -4.8% | -8,79 -8,80 0.07% | -13,3 -14,2 6.43% | -11,5 -12,4 7.42% | -10,8 -12,0 9.78% | -9,60 |
|
EPS USD | Released Forecast Spread | -2 088 -2 020 -3.37% | -207 -207 0% | -112 -120 6.31% | -90,9 -98,3 7.51% | -46,8 -56,3 16.93% | -16,4 |
| Announcement Date | 26/03/20 | 25/03/21 | 22/03/22 | 22/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 12,5 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | ||
|
EBIT Million USD | Released Forecast Spread | -2,64 -4,10 35.61% | -2,52 -4,10 38.51% | -3,57 9,90 -136.07% | -2,73 -3,70 26.22% | -2,78 -2,80 0.86% | -1,90 -3,10 38.74% | -2,30 | -2,50 | -2,60 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,64 -4,10 35.56% | -2,53 -4,10 38.27% | -3,58 9,90 -136.12% | -2,73 -3,70 26.19% | -2,78 -2,80 0.71% | -1,90 -3,10 38.87% | -2,30 | -2,50 | -2,60 | ||
|
Net income Million USD | Released Forecast Spread | -2,64 -4,10 35.56% | -2,53 -4,10 38.27% | -3,58 7,50 -147.68% | -2,73 -3,70 26.19% | -2,55 | -2,78 -2,80 0.71% | -1,90 -3,10 38.87% | -2,15 | -2,30 | -2,50 | -2,60 |
|
EPS USD | Released Forecast Spread | -20,5 -32,4 36.67% | -20,5 -33,5 38.71% | -28,1 38,9 -172.22% | -21,8 -29,2 25.31% | -13,2 | -10,3 -12,9 20.28% | -1,53 -11,7 86.92% | -4,23 | -4,59 | -4,14 | -3,60 |
| Announcement Date | 12/05/22 | 11/08/22 | 10/11/22 | 22/03/23 | 10/08/23 | 09/11/23 | 01/04/24 | 09/05/24 | - | - | - |
| 2024-07-15 01:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 2024-07-26 01:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Phio Pharmaceuticals Corp.
| 2024-06-07 02:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 2024-05-29 16:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 2024-05-23 07:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 17:14 | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 16:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PHIO Stock
- Calendar Phio Pharmaceuticals Corp.
